Intracellular Routing and Recognition of Lipid-Based mRNA Nanoparticles
Messenger RNA (mRNA) is being extensively used in gene therapy and vaccination due to its safety over DNA, in the following ways: its lack of integration risk, cytoplasmic expression, and transient expression compatible with fine regulations. However, clinical applications of mRNA are limited by its...
Main Authors: | Christophe Delehedde, Luc Even, Patrick Midoux, Chantal Pichon, Federico Perche |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-06-01
|
Series: | Pharmaceutics |
Subjects: | |
Online Access: | https://www.mdpi.com/1999-4923/13/7/945 |
Similar Items
-
In Cellulo and In Vivo Comparison of Cholesterol, Beta-Sitosterol and Dioleylphosphatidylethanolamine for Lipid Nanoparticle Formulation of mRNA
by: Ayoub Medjmedj, et al.
Published: (2022-07-01) -
Nanotechnology-Enabled COVID-19 mRNA Vaccines
by: Yu Gao, et al.
Published: (2021-08-01) -
Ionizable Lipid Nanoparticles for mRNA Delivery
by: Xuefeng Tang, et al.
Published: (2023-08-01) -
Development of a Novel Lipid-Based Nanosystem Functionalized with WGA for Enhanced Intracellular Drug Delivery
by: Gabriela Hädrich, et al.
Published: (2022-09-01) -
Optimization of ionizable lipids for aerosolizable mRNA lipid nanoparticles
by: Mae M. Lewis, et al.
Published: (2023-11-01)